Neurodevelopmental Follow Up After Therapeutic Hypothermia for Perinatal Asphyxia

Area of Science:

• Neonatal Medicine
• Pediatric Neurology
• Therapeutic Hypothermia

Background:

• Hypoxic-ischemic encephalopathy (HIE) poses significant risks to term newborns.
• Therapeutic hypothermia is a potential neuroprotective strategy for HIE.
• Assessing long-term survival and neurodevelopmental outcomes is crucial.

Purpose of the Study:

• To evaluate the neuroprotective effects of therapeutic hypothermia in term newborns with HIE.
• To analyze survival rates and neurodevelopmental outcomes following the procedure.
• To identify potential correlations between baseline parameters and patient outcomes.

Main Methods:

• A cooling protocol was applied to newborns with moderate to severe asphyxial encephalopathy.
• Infants were cooled to 33.5°C for 72 hours, followed by a 6-hour rewarming period.
• Neurodevelopmental assessments were conducted using the ASQ-3 at multiple time points (3-6, 12-18, 24-36 months).

Main Results:

• Fourteen out of 25 (16%) infants died during the study period.
• Neurodevelopmental assessments showed variable results across different domains and time points.
• Fine motor skills consistently presented the highest need for retesting across assessments.

Conclusions:

• Therapeutic hypothermia in term newborns with HIE is associated with improved survival rates.
• The procedure appears to reduce the incidence of neurological sequelae in HIE patients.
• No significant correlation was found between baseline clinical parameters and long-term outcomes.